| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |